{
    "2018-01-12": [
        [
            {
                "time": "",
                "original_text": "中生制药涨半成破顶 获瑞信升目标价",
                "features": {
                    "keywords": [
                        "中生制药",
                        "涨半成",
                        "破顶",
                        "瑞信",
                        "升目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "全国进入流感高发期，多家上市药企回应旗下产品情况",
                "features": {
                    "keywords": [
                        "流感高发期",
                        "上市药企",
                        "产品情况"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "全国进入流感高发期 多家上市药企回应旗下产品情况",
                "features": {
                    "keywords": [
                        "流感高发期",
                        "上市药企",
                        "产品情况"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "*里昂看好内地药物分销行业 首予上海医药(02607.HK)「跑赢大市」评级",
                "features": {
                    "keywords": [
                        "里昂",
                        "看好",
                        "内地药物分销",
                        "上海医药",
                        "跑赢大市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "盘点：赛默飞2017色谱与质谱“搞事情”",
                "features": {
                    "keywords": [
                        "赛默飞",
                        "2017",
                        "色谱",
                        "质谱",
                        "搞事情"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}